Cargando…
Erratum to: Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
Autores principales: | Wu, Xing, Wu, Fenlang, Xu, Dongwen, Zhang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969914/ https://www.ncbi.nlm.nih.gov/pubmed/26915103 http://dx.doi.org/10.1007/s11060-016-2089-x |
Ejemplares similares
-
Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
por: Wu, Xing, et al.
Publicado: (2016) -
Erratum to: Prognostic value of O(6)-methylguanine-DNA methyltransferase methylation in isocitrate dehydrogenase mutant gliomas
Publicado: (2022) -
Erratum to: Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma
por: Song, Ye, et al.
Publicado: (2015) -
Erratum to: Prognostic Markers in Peripheral T-Cell Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2010) -
CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies: Erratum
Publicado: (2018)